Sonovascular, Inc

SonoVascular has developed the SonoThrombectomy™ System, a novel and differentiated ultrasound facilitated, thrombolytic enhanced thrombectomy system that utilizes microbubble-mediated cavitation as a core enabling mechanical mechanism of action to treat blood clots more safely and effectively. It is a mechanical-pharmaco cathlab-based solution designed to treat patients in a single session, standalone cathlab-based procedure, with maximum clot reduction, no blood loss or no vascular trauma. Initial clinical results indicate the SonoThrombectomy System has the potential to redefine how clinicians approach clot management, offering a transformative alternative to today’s incremental innovations.